CTOs on the Move

All Together Now

www.alltogethernow.com

 
All Together Now is a Boise, ID-based company in the Business Services sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Ellgee Uniform Shop

Ellgee Uniform Shop is a New Orleans, LA-based company in the Business Services sector.

Rogina and Associates

Rogina and Associates is one of the leading companies in Business Services industry. Rogina and Associates is based in Joliet, IL. You can find more information on Rogina and Associates at www.rogina.com

First Growth Holdings

First Growth Holdings Ltd. (First Growth) is a Canadian based company that identifies and develops strong brands in the Canadian and International markets. Strong brands have a global reach in today`s modern world with the rapid adoption of social media and advancements in technology. First Growth recognizes the potential for certain brands to penetrate International markets and will be focused on developing each one of its brands to its fullest potential.

Blue State Digital

Blue State Digital is a New York, NY-based company in the Business Services sector.

Skye Bioscience Inc.

Skye Bioscience Inc. is a clinical-stage biotechnology company based in San Diego, California. The company focuses on developing innovative therapeutics for metabolic diseases, particularly obesity, by modulating the endocannabinoid system. Skye Bioscience is advancing its lead product, Nimacimab, a monoclonal antibody that targets peripheral CB1 receptors. This treatment aims to provide effective weight loss solutions while minimizing neuropsychiatric side effects associated with previous therapies. Nimacimab is currently in a Phase 2 trial, evaluating its efficacy in weight loss and metabolic health. The company is also exploring combination therapies to enhance treatment outcomes. Skye Bioscience positions Nimacimab as a potential alternative to existing GLP-1-based therapies, targeting patients who need sustainable weight loss with improved safety profiles. The obesity drug market presents significant opportunities, and Skye is actively participating in clinical trials and industry conferences to advance its mission in metabolic health.